Tania M Nanevicz, MD
Cardiovascular Disease (Cardiology) · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nanevicz’s office at (415) 600-1020 to ask if they take your plan before you enroll.
California Medical Board record
Licence G77614 · Current
Licensed to practise in California · since 1993 · expires 2027-06-30 · Brown University Program in Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$254,043
Medicare paid this office $254,043 for 1,230 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 410 | $85,064 | $192 |
| Return visit (30+ min) | 432 | $71,978 | $113 |
| Critical care, first 30-74 minutes | 77 | $18,089 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 273 | $16,080 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $13,734 | $103 |
See all 22 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 410 | $85,064 | $192 |
| Return visit (30+ min) | 432 | $71,978 | $113 |
| Critical care, first 30-74 minutes | 77 | $18,089 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 273 | $16,080 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $13,734 | $103 |
| New patient visit (45+ min) | 68 | $9,482 | $139 |
| Long return visit (40+ min) | 44 | $8,748 | $165 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $5,536 | $213 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $5,287 | $143 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 198 | $2,532 | $12 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,151 | $113 |
| Ultrasound of heart, follow-up | 88 | $2,027 | $22 |
| Ultrasound of heart, follow-up | 17 | $1,778 | $105 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 95 | $1,443 | $15 |
| Interpretation and report of ultrasound of heart | 14 | $1,116 | $74 |
| 3d radiographic procedure | 39 | $1,026 | $26 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $787 | $25 |
| Heart muscle strain imaging | 19 | $774 | $39 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 28 | $736 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 65 | $493 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 56 | $369 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 69 | $208 | $3 |
Who their Medicare patients are
1,230 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 29% · Women 55% · Also on Medicaid 10% · Health risk score 1.56. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 45% · Coronary heart disease 44% · Heart failure 37% · Chronic kidney disease 34% · Diabetes 32% · Cancer 20% · COPD 17% · Depression 17% · Dementia 11% · Stroke 11%.
The office billed $1,103,768, Medicare allowed $337,642 and paid $254,043; for 2,603 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,230 | 2,603 | 79 | 1.56 | $1,103,768 | $254,043 |
| 2023 | 1,465 | 2,828 | 79 | 1.59 | $883,776 | $214,976 |
| 2022 | 1,078 | 2,216 | 78 | 1.51 | $717,842 | $183,593 |
| 2021 | 1,174 | 2,502 | 78 | 1.63 | $826,075 | $218,812 |
| 2020 | 973 | 2,069 | 78 | 1.62 | $621,284 | $171,369 |
| 2019 | 1,132 | 2,336 | 78 | 1.64 | $837,968 | $195,326 |
| 2018 | 708 | 1,618 | 79 | 1.61 | $602,295 | $156,725 |
| 2017 | 569 | 1,469 | 79 | 1.71 | $525,202 | $144,283 |
| 2016 | 670 | 1,564 | 79 | 1.80 | $568,678 | $157,855 |
| 2015 | 574 | 1,463 | 78 | 1.80 | $537,841 | $155,306 |
| 2014 | 567 | 1,594 | 78 | 1.52 | $515,326 | $145,755 |
| 2013 | 487 | 1,255 | 79 | 1.62 | $441,842 | $119,254 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 428 | $63,811 | $112 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $51,892 | $191 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 224 | $14,172 | $62 |
| Critical care, first 30-74 minutes | 54 | $13,374 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $11,792 | $106 |
| Long return visit (40+ min) | 62 | $10,734 | $151 |
| New patient visit (45+ min) | 65 | $10,027 | $154 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 523 | $8,057 | $14 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $7,640 | $232 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,167 | $144 |
| Interpretation and report of ultrasound of heart | 29 | $2,767 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 290 | $2,495 | $7 |
| Ultrasound of heart, follow-up | 66 | $1,622 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,541 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,412 | $109 |
| Ultrasound of heart, follow-up | 13 | $1,360 | $105 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 12 | $1,195 | $52 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $691 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 24 | $638 | $27 |
| Heart muscle strain imaging | 13 | $508 | $39 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $426 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 48 | $332 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 58 | $182 | $3 |
2022: 17 services
| Return visit (30+ min) | 382 | $58,424 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 203 | $40,447 | $194 |
| Long return visit (40+ min) | 80 | $16,444 | $158 |
| Critical care, first 30-74 minutes | 59 | $13,653 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 165 | $10,664 | $63 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 37 | $8,261 | $223 |
| New patient visit (45+ min) | 58 | $7,981 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $7,440 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 295 | $4,504 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,297 | $177 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 244 | $2,108 | $7 |
| Interpretation and report of ultrasound of heart | 13 | $1,034 | $80 |
| Ultrasound of heart, follow-up | 40 | $957 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 16 | $393 | $25 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 40 | $272 | $6 |
| Heart rhythm recording of continous external ekg over 8-15 days | 16 | $245 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 41 | $122 | $3 |
2021: 16 services
| Return visit (30+ min) | 327 | $54,009 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 255 | $52,824 | $200 |
| Long return visit (40+ min) | 126 | $27,241 | $155 |
| Critical care, first 30-74 minutes | 79 | $18,974 | $184 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 274 | $17,968 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $8,306 | $92 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 28 | $6,928 | $239 |
| New patient visit (45+ min) | 47 | $6,831 | $145 |
| New patient visit (60+ min) | 31 | $5,817 | $188 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 243 | $3,903 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,247 | $180 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 288 | $2,381 | $7 |
| Ultrasound of heart, follow-up | 56 | $1,405 | $23 |
| Interpretation and report of ultrasound of heart | 12 | $901 | $75 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 53 | $380 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 55 | $175 | $3 |
2020: 20 services
| Return visit (30+ min) | 286 | $41,324 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 192 | $40,175 | $195 |
| Telephone medical discussion with physician, 21-30 minutes | 112 | $14,769 | $100 |
| Critical care, first 30-74 minutes | 57 | $14,128 | $191 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 201 | $13,922 | $68 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $9,371 | $95 |
| Long return visit (40+ min) | 39 | $6,080 | $129 |
| New patient visit (45+ min) | 40 | $5,912 | $148 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 20 | $4,644 | $232 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 185 | $3,059 | $15 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,036 | $179 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $2,071 | $65 |
| Ultrasound of heart, follow-up | 15 | $1,758 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 183 | $1,656 | $8 |
| Interpretation and report of ultrasound of heart | 16 | $1,286 | $80 |
| Ultrasound of heart, follow-up | 37 | $977 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $460 | $26 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $453 | $27 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 37 | $277 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $122 | $3 |
2019: 18 services
| Return visit (30+ min) | 366 | $57,172 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 254 | $51,188 | $196 |
| Critical care, first 30-74 minutes | 62 | $17,685 | $192 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 197 | $13,448 | $67 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 52 | $11,872 | $220 |
| New patient visit (45+ min) | 69 | $9,561 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $8,135 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 346 | $6,178 | $16 |
| Long return visit (40+ min) | 36 | $5,535 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,370 | $182 |
| Ultrasound of heart, follow-up | 20 | $1,951 | $98 |
| Interpretation and report of ultrasound of heart | 20 | $1,636 | $82 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 169 | $1,492 | $8 |
| Ultrasound of heart, follow-up | 41 | $1,058 | $24 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 20 | $532 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $505 | $27 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 41 | $300 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 45 | $144 | $3 |
2018: 14 services
| Return visit (30+ min) | 327 | $51,737 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 206 | $42,910 | $201 |
| Critical care, first 30-74 minutes | 56 | $12,189 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $10,283 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 37 | $8,474 | $229 |
| Long return visit (40+ min) | 46 | $7,157 | $119 |
| New patient visit (45+ min) | 40 | $5,852 | $146 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $4,944 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 195 | $3,845 | $16 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,564 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 47 | $406 | $8 |
| Ultrasound of heart, follow-up | 11 | $254 | $23 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $72 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $46 | $3 |
2017: 14 services
| Return visit (30+ min) | 270 | $49,482 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 179 | $41,386 | $217 |
| Critical care, first 30-74 minutes | 45 | $14,373 | $194 |
| Long return visit (40+ min) | 65 | $9,328 | $124 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $6,024 | $274 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $5,731 | $90 |
| New patient visit (45+ min) | 25 | $3,641 | $146 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 150 | $3,065 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 37 | $2,126 | $57 |
| New patient visit (60+ min) | 12 | $1,914 | $159 |
| Programming of dual lead pacemaker system | 12 | $835 | $52 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $618 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 67 | $564 | $7 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 15 | $327 | $12 |
2016: 14 services
| Return visit (30+ min) | 302 | $46,704 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 171 | $38,945 | $223 |
| Long return visit (40+ min) | 110 | $18,660 | $125 |
| Critical care, first 30-74 minutes | 65 | $16,616 | $193 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 25 | $6,880 | $275 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $5,836 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 79 | $4,583 | $57 |
| New patient visit (60+ min) | 22 | $3,923 | $178 |
| New patient visit (45+ min) | 25 | $3,560 | $142 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 151 | $2,934 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 11 | $1,038 | $86 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 87 | $750 | $7 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $286 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $247 | $22 |
2015: 11 services
| Return visit (30+ min) | 286 | $54,325 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 135 | $33,199 | $234 |
| Critical care, first 30-74 minutes | 76 | $18,082 | $205 |
| Long return visit (40+ min) | 73 | $12,419 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $9,477 | $98 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $6,078 | $59 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $3,922 | $280 |
| New patient visit (45+ min) | 22 | $3,011 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 140 | $2,455 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,191 | $79 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $262 | $8 |
2014: 14 services
| Return visit (30+ min) | 285 | $57,295 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 124 | $28,679 | $226 |
| Critical care, first 30-74 minutes | 47 | $11,140 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $10,268 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $8,536 | $267 |
| New patient visit (45+ min) | 49 | $7,141 | $146 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $4,881 | $56 |
| Transitional care management services for problem of high complexity | 13 | $3,056 | $218 |
| Long return visit (40+ min) | 23 | $3,012 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 130 | $2,294 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $1,174 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 136 | $969 | $7 |
| Short return visit (20+ min) | 12 | $670 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 59 | $522 | $8 |
2013: 13 services
| Return visit (30+ min) | 262 | $52,658 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 104 | $19,787 | $185 |
| Critical care, first 30-74 minutes | 44 | $9,539 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $8,274 | $90 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 22 | $5,061 | $230 |
| New patient visit (45+ min) | 34 | $5,005 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 59 | $3,368 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 111 | $2,340 | $16 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,903 | $119 |
| Short return visit (20+ min) | 26 | $1,678 | $56 |
| Long return visit (40+ min) | 11 | $1,465 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,129 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $193 | $7 |
Medicaid work
$12,965 in 2024
Medicaid paid $12,965 for 167 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 167 | $12,965 |
| 2024 | 167 | 1 | 24 | $12,965 |
| 2023 | 222 | 3 | 23 | $9,273 |
| 2022 | 114 | 2 | 20 | $2,449 |
| 2021 | 232 | 2 | 25 | $10,156 |
| 2020 | 116 | 2 | 22 | $7,333 |
| 2019 | 135 | 2 | 24 | $4,755 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 127 | $8,430 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 76 | $584 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 19 | $258 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 28 | $1,505 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 86 | $944 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 147 | $9,199 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 85 | $958 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 94 | $7,140 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 22 | $193 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 70 | $4,198 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 65 | $557 |
Drugs they prescribed that Part D paid
$1,015,638
Pharmacies billed $1,015,638 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,022) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
3,285 generic and 737 brand-name prescriptions · $1,015,638 in drug cost · 18 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 410 | $615,181 | $1,500 |
| Entresto | 79 | $84,434 | $1,069 |
| Xarelto | 59 | $78,748 | $1,335 |
| Repatha Sureclick | 55 | $54,008 | $982 |
| Farxiga | 31 | $33,185 | $1,070 |
See all 37 drugs
| Eliquis | 410 | $615,181 | $1,500 |
| Entresto | 79 | $84,434 | $1,069 |
| Xarelto | 59 | $78,748 | $1,335 |
| Repatha Sureclick | 55 | $54,008 | $982 |
| Farxiga | 31 | $33,185 | $1,070 |
| Jardiance | 22 | $29,535 | $1,343 |
| Praluent | 18 | $18,659 | $1,037 |
| Atorvastatin | 493 | $7,508 | $15 |
| Metoprolol | 353 | $7,336 | $21 |
| Valsartan | 104 | $4,342 | $42 |
| Ezetimibe | 116 | $4,112 | $35 |
| Losartan | 277 | $3,024 | $11 |
| Diltiazem 24hr Er (Cd) | 88 | $2,941 | $33 |
| Irbesartan | 103 | $2,607 | $25 |
| Amlodipine Besylate | 332 | $2,420 | $7 |
| Rosuvastatin | 131 | $2,369 | $18 |
| Carvedilol | 155 | $1,667 | $11 |
| Clopidogrel | 97 | $1,633 | $17 |
| Lisinopril | 142 | $1,174 | $8 |
| Valsartan-Hydrochlorothiazide | 15 | $1,070 | $71 |
| Pravastatin | 60 | $981 | $16 |
| Spironolactone | 88 | $980 | $11 |
| Furosemide | 150 | $822 | $5 |
| Torsemide | 26 | $814 | $31 |
| Simvastatin | 38 | $586 | $15 |
| Isosorbide Mononitrate Er | 13 | $565 | $43 |
| Bisoprolol | 19 | $552 | $29 |
| Potassium Chloride | 28 | $502 | $18 |
| Hydralazine | 30 | $487 | $16 |
| Isosorbide Mononitrate | 20 | $422 | $21 |
| Amiodarone | 15 | $329 | $22 |
| Atenolol | 25 | $310 | $12 |
| Hydrochlorothiazide | 60 | $251 | $4 |
| Metoprolol | 48 | $227 | $5 |
| Pantoprazole | 20 | $218 | $11 |
| Losartan-Hydrochlorothiazide | 15 | $112 | $7 |
| Amoxicillin | 15 | $67 | $4 |
Year by year
| 2024 | 4,022 | 602 | 0% (0) | 18% | $1,015,638 |
| 2023 | 3,891 | 588 | 0% (0) | 18% | $920,979 |
| 2022 | 3,636 | 490 | 0% (0) | 17% | $729,439 |
| 2021 | 3,418 | 434 | 0% (0) | 18% | $636,065 |
| 2020 | 3,435 | 408 | 0% (0) | 20% | $580,870 |
| 2019 | 3,051 | 386 | 0% (0) | 18% | $424,794 |
| 2018 | 2,974 | 365 | 0% (0) | 18% | $390,440 |
| 2017 | 3,156 | 362 | None | None | $348,177 |
| 2016 | 3,007 | 325 | 0% (0) | 22% | $304,656 |
| 2015 | 3,132 | 302 | None | 21% | $241,061 |
| 2014 | 2,969 | 291 | None | None | $195,414 |
| 2013 | 2,878 | 280 | None | None | $142,475 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 40 drugs
| Eliquis | 438 | $588,605 | $1,344 |
| Xarelto | 64 | $78,540 | $1,227 |
| Entresto | 61 | $65,719 | $1,077 |
| Repatha Sureclick | 43 | $41,993 | $977 |
| Praluent | 14 | $17,739 | $1,267 |
| Atorvastatin | 461 | $8,409 | $18 |
| Metoprolol | 338 | $8,377 | $25 |
| Ezetimibe | 84 | $5,139 | $61 |
| Rosuvastatin | 130 | $4,941 | $38 |
| Irbesartan | 105 | $4,393 | $42 |
| Valsartan | 67 | $4,241 | $63 |
| Diltiazem 24hr Er (Cd) | 75 | $3,546 | $47 |
| Losartan | 231 | $3,255 | $14 |
| Amlodipine Besylate | 350 | $3,219 | $9 |
| Carvedilol | 182 | $2,803 | $15 |
| Dofetilide | 15 | $1,597 | $106 |
| Isosorbide Mononitrate | 24 | $1,559 | $65 |
| Spironolactone | 93 | $1,444 | $16 |
| Clopidogrel | 70 | $1,390 | $20 |
| Clonidine | 13 | $1,334 | $103 |
| Torsemide | 27 | $1,202 | $45 |
| Lisinopril | 148 | $1,160 | $8 |
| Furosemide | 160 | $1,095 | $7 |
| Pravastatin | 64 | $1,066 | $17 |
| Bisoprolol | 22 | $706 | $32 |
| Simvastatin | 31 | $602 | $19 |
| Hydralazine | 29 | $565 | $19 |
| Losartan-Hydrochlorothiazide | 14 | $519 | $37 |
| Potassium Chloride | 30 | $506 | $17 |
| Chlorthalidone | 15 | $474 | $32 |
| Atenolol | 27 | $414 | $15 |
| Isosorbide Mononitrate Er | 17 | $390 | $23 |
| Pantoprazole | 26 | $368 | $14 |
| Spironolactone-Hctz | 11 | $353 | $32 |
| Metoprolol | 43 | $310 | $7 |
| Amiodarone | 15 | $288 | $19 |
| Hydrochlorothiazide | 70 | $281 | $4 |
| Sotalol | 20 | $280 | $14 |
| Allopurinol | 18 | $127 | $7 |
| Amoxicillin | 13 | $24 | $2 |
2022: 39 drugs
| Eliquis | 425 | $498,325 | $1,173 |
| Xarelto | 61 | $70,819 | $1,161 |
| Entresto | 21 | $17,086 | $814 |
| Praluent | 13 | $10,400 | $800 |
| Dofetilide | 28 | $8,601 | $307 |
| Atorvastatin | 496 | $8,368 | $17 |
| Metoprolol | 320 | $8,087 | $25 |
| Irbesartan | 84 | $4,439 | $53 |
| Rosuvastatin | 95 | $4,393 | $46 |
| Ezetimibe | 63 | $4,321 | $69 |
| Losartan | 243 | $4,216 | $17 |
| Amlodipine Besylate | 329 | $3,048 | $9 |
| Valsartan | 62 | $2,923 | $47 |
| Diltiazem 24hr Er (Cd) | 62 | $2,812 | $45 |
| Carvedilol | 168 | $2,765 | $16 |
| Clonidine | 18 | $2,282 | $127 |
| Ezetimibe-Simvastatin | 12 | $2,088 | $174 |
| Lisinopril | 167 | $1,331 | $8 |
| Losartan-Hydrochlorothiazide | 14 | $1,318 | $94 |
| Pravastatin | 57 | $1,259 | $22 |
| Torsemide | 33 | $1,245 | $38 |
| Clopidogrel | 66 | $1,194 | $18 |
| Spironolactone | 72 | $1,179 | $16 |
| Potassium Chloride | 27 | $1,048 | $39 |
| Furosemide | 120 | $918 | $8 |
| Hydralazine | 24 | $848 | $35 |
| Isosorbide Mononitrate | 14 | $700 | $50 |
| Allopurinol | 25 | $675 | $27 |
| Simvastatin | 45 | $539 | $12 |
| Atenolol | 31 | $462 | $15 |
| Amiodarone | 25 | $421 | $17 |
| Metoprolol | 40 | $411 | $10 |
| Hydrochlorothiazide | 74 | $387 | $5 |
| Sotalol | 18 | $315 | $18 |
| Levothyroxine | 11 | $229 | $21 |
| Bisoprolol | 12 | $186 | $16 |
| Pantoprazole | 18 | $165 | $9 |
| Triamterene-Hydrochlorothiazid | 15 | $99 | $7 |
| Lovastatin | 11 | $70 | $6 |
2021: 39 drugs
| Eliquis | 409 | $446,122 | $1,091 |
| Xarelto | 37 | $51,230 | $1,385 |
| Praluent | 32 | $19,499 | $609 |
| Entresto | 21 | $15,891 | $757 |
| Metoprolol | 333 | $9,686 | $29 |
| Atorvastatin | 427 | $7,503 | $18 |
| Irbesartan | 95 | $5,299 | $56 |
| Rosuvastatin | 101 | $4,705 | $47 |
| Diltiazem 24hr Er (Cd) | 63 | $3,635 | $58 |
| Losartan | 218 | $3,444 | $16 |
| Amlodipine Besylate | 311 | $3,096 | $10 |
| Valsartan | 42 | $2,989 | $71 |
| Ezetimibe | 38 | $2,935 | $77 |
| Carvedilol | 162 | $2,379 | $15 |
| Amiodarone | 46 | $2,220 | $48 |
| Clonidine | 18 | $2,120 | $118 |
| Dofetilide | 15 | $2,062 | $137 |
| Lisinopril | 199 | $1,429 | $7 |
| Pravastatin | 50 | $1,128 | $23 |
| Losartan-Hydrochlorothiazide | 12 | $1,064 | $89 |
| Clopidogrel | 57 | $1,046 | $18 |
| Spironolactone | 66 | $908 | $14 |
| Furosemide | 111 | $821 | $7 |
| Torsemide | 28 | $762 | $27 |
| Potassium Chloride | 19 | $576 | $30 |
| Bisoprolol | 13 | $552 | $42 |
| Simvastatin | 57 | $524 | $9 |
| Allopurinol | 17 | $474 | $28 |
| Metoprolol | 40 | $436 | $11 |
| Sotalol | 20 | $387 | $19 |
| Hydrochlorothiazide | 65 | $387 | $6 |
| Hydralazine | 18 | $376 | $21 |
| Isosorbide Mononitrate Er | 18 | $374 | $21 |
| Olmesartan Medoxomil | 12 | $370 | $31 |
| Atenolol | 26 | $251 | $10 |
| Lovastatin | 16 | $198 | $12 |
| Benazepril | 12 | $118 | $10 |
| Pantoprazole | 15 | $72 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $65 | $5 |
2020: 40 drugs
| Eliquis | 411 | $389,780 | $948 |
| Xarelto | 64 | $54,234 | $847 |
| Praluent | 20 | $12,500 | $625 |
| Metoprolol | 332 | $11,713 | $35 |
| Pradaxa | 14 | $9,477 | $677 |
| Atorvastatin | 360 | $8,006 | $22 |
| Diltiazem 24hr Er (Cd) | 89 | $6,593 | $74 |
| Rosuvastatin | 75 | $4,479 | $60 |
| Irbesartan | 62 | $4,084 | $66 |
| Valsartan | 37 | $3,400 | $92 |
| Losartan | 227 | $3,293 | $15 |
| Colchicine | 12 | $3,250 | $271 |
| Carvedilol | 172 | $2,447 | $14 |
| Amlodipine Besylate | 255 | $2,116 | $8 |
| Flecainide Acetate | 14 | $2,019 | $144 |
| Ezetimibe | 26 | $1,801 | $69 |
| Bisoprolol | 21 | $1,590 | $76 |
| Lisinopril | 198 | $1,531 | $8 |
| Clonidine | 14 | $1,505 | $108 |
| Clopidogrel | 64 | $1,479 | $23 |
| Pravastatin | 54 | $1,239 | $23 |
| Amiodarone | 47 | $1,132 | $24 |
| Furosemide | 124 | $1,108 | $9 |
| Sotalol | 18 | $1,053 | $58 |
| Spironolactone | 62 | $939 | $15 |
| Torsemide | 44 | $915 | $21 |
| Potassium Chloride | 25 | $777 | $31 |
| Cartia Xt | 15 | $727 | $48 |
| Allopurinol | 22 | $645 | $29 |
| Isosorbide Mononitrate Er | 30 | $610 | $20 |
| Simvastatin | 58 | $603 | $10 |
| Metoprolol | 48 | $533 | $11 |
| Hydrochlorothiazide | 88 | $532 | $6 |
| Olmesartan Medoxomil | 16 | $530 | $33 |
| Levothyroxine | 15 | $469 | $31 |
| Atenolol | 23 | $286 | $12 |
| Nitroglycerin | 12 | $226 | $19 |
| Lovastatin | 15 | $161 | $11 |
| Pantoprazole | 18 | $157 | $9 |
| Triamterene-Hydrochlorothiazid | 14 | $120 | $9 |
2019: 42 drugs
| Eliquis | 299 | $259,694 | $869 |
| Xarelto | 76 | $57,071 | $751 |
| Metoprolol | 296 | $13,057 | $44 |
| Atorvastatin | 262 | $6,482 | $25 |
| Pradaxa | 11 | $5,968 | $543 |
| Rosuvastatin | 75 | $4,141 | $55 |
| Losartan | 166 | $2,550 | $15 |
| Carvedilol | 171 | $2,457 | $14 |
| Amlodipine Besylate | 256 | $2,381 | $9 |
| Valsartan | 29 | $2,162 | $75 |
| Lisinopril | 204 | $2,057 | $10 |
| Irbesartan | 47 | $1,821 | $39 |
| Diltiazem 24hr Er (Cd) | 40 | $1,759 | $44 |
| Amiodarone | 43 | $1,748 | $41 |
| Pravastatin | 50 | $1,608 | $32 |
| Bisoprolol | 21 | $1,577 | $75 |
| Flecainide Acetate | 12 | $1,474 | $123 |
| Ezetimibe | 24 | $1,385 | $58 |
| Furosemide | 117 | $1,319 | $11 |
| Enalapril Maleate | 16 | $1,207 | $75 |
| Clopidogrel | 54 | $1,139 | $21 |
| Potassium Chloride | 31 | $952 | $31 |
| Cartia Xt | 19 | $808 | $43 |
| Isosorbide Mononitrate Er | 23 | $795 | $35 |
| Labetalol | 11 | $712 | $65 |
| Simvastatin | 67 | $670 | $10 |
| Spironolactone | 55 | $669 | $12 |
| Torsemide | 41 | $647 | $16 |
| Sotalol | 25 | $633 | $25 |
| Allopurinol | 27 | $632 | $23 |
| Olmesartan Medoxomil | 11 | $575 | $52 |
| Metoprolol | 53 | $524 | $10 |
| Hydrochlorothiazide | 80 | $506 | $6 |
| Hydralazine | 17 | $467 | $27 |
| Levothyroxine | 14 | $450 | $32 |
| Diltiazem | 13 | $372 | $29 |
| Verapamil Er | 13 | $300 | $23 |
| Nitroglycerin | 14 | $299 | $21 |
| Triamterene-Hydrochlorothiazid | 17 | $199 | $12 |
| Lovastatin | 19 | $187 | $10 |
| Atenolol | 24 | $178 | $7 |
| Pantoprazole | 11 | $171 | $16 |
2018: 42 drugs
| Eliquis | 287 | $215,239 | $750 |
| Xarelto | 87 | $65,341 | $751 |
| Praluent | 13 | $14,762 | $1,136 |
| Metoprolol | 255 | $11,665 | $46 |
| Pradaxa | 12 | $7,773 | $648 |
| Atorvastatin | 220 | $5,617 | $26 |
| Rosuvastatin | 53 | $3,042 | $57 |
| Ezetimibe | 25 | $2,947 | $118 |
| Valsartan | 41 | $2,657 | $65 |
| Amlodipine Besylate | 262 | $2,389 | $9 |
| Losartan | 175 | $2,281 | $13 |
| Carvedilol | 181 | $2,185 | $12 |
| Lisinopril | 239 | $1,932 | $8 |
| Pravastatin | 41 | $1,691 | $41 |
| Flecainide Acetate | 19 | $1,657 | $87 |
| Diltiazem 24hr Er (Cd) | 17 | $1,534 | $90 |
| Potassium Chloride | 35 | $1,300 | $37 |
| Irbesartan | 52 | $1,223 | $24 |
| Bisoprolol | 21 | $1,129 | $54 |
| Cartia Xt | 36 | $1,114 | $31 |
| Sotalol Af | 13 | $1,071 | $82 |
| Enalapril Maleate | 11 | $974 | $89 |
| Sotalol | 26 | $813 | $31 |
| Clopidogrel | 43 | $760 | $18 |
| Furosemide | 107 | $731 | $7 |
| Isosorbide Mononitrate Er | 26 | $682 | $26 |
| Spironolactone | 51 | $663 | $13 |
| Simvastatin | 73 | $654 | $9 |
| Allopurinol | 22 | $639 | $29 |
| Chlorthalidone | 11 | $586 | $53 |
| Torsemide | 32 | $573 | $18 |
| Amiodarone | 19 | $544 | $29 |
| Verapamil Er | 16 | $536 | $34 |
| Metoprolol | 67 | $522 | $8 |
| Hydrochlorothiazide | 97 | $474 | $5 |
| Levothyroxine | 14 | $423 | $30 |
| Nitroglycerin | 17 | $403 | $24 |
| Triamterene-Hydrochlorothiazid | 22 | $325 | $15 |
| Lovastatin | 21 | $324 | $15 |
| Atenolol | 17 | $201 | $12 |
| Benazepril | 13 | $150 | $12 |
| Mirtazapine | 11 | $60 | $5 |
2017: 40 drugs
| Eliquis | 324 | $186,819 | $577 |
| Xarelto | 66 | $50,199 | $761 |
| Zetia | 15 | $11,864 | $791 |
| Pradaxa | 22 | $10,967 | $498 |
| Metoprolol | 226 | $8,636 | $38 |
| Atorvastatin | 205 | $4,883 | $24 |
| Valsartan | 66 | $4,370 | $66 |
| Crestor | 13 | $3,964 | $305 |
| Diltiazem 24hr Er | 28 | $3,474 | $124 |
| Flecainide Acetate | 30 | $3,444 | $115 |
| Ezetimibe | 13 | $2,737 | $211 |
| Rosuvastatin | 27 | $2,544 | $94 |
| Losartan | 253 | $2,524 | $10 |
| Amlodipine Besylate | 282 | $2,179 | $8 |
| Carvedilol | 187 | $1,926 | $10 |
| Pravastatin | 40 | $1,689 | $42 |
| Lisinopril | 207 | $1,463 | $7 |
| Potassium Chloride | 44 | $1,437 | $33 |
| Bisoprolol | 29 | $1,321 | $46 |
| Cartia Xt | 31 | $1,084 | $35 |
| Enalapril Maleate | 14 | $980 | $70 |
| Clopidogrel | 52 | $888 | $17 |
| Torsemide | 40 | $823 | $21 |
| Chlorthalidone | 19 | $817 | $43 |
| Simvastatin | 104 | $793 | $8 |
| Isosorbide Mononitrate Er | 23 | $669 | $29 |
| Spironolactone | 46 | $613 | $13 |
| Amiodarone | 25 | $607 | $24 |
| Furosemide | 150 | $597 | $4 |
| Allopurinol | 23 | $577 | $25 |
| Irbesartan | 25 | $473 | $19 |
| Hydrochlorothiazide | 110 | $469 | $4 |
| Metoprolol | 57 | $394 | $7 |
| Sotalol | 21 | $345 | $16 |
| Verapamil Er | 12 | $328 | $27 |
| Atenolol | 43 | $318 | $7 |
| Triamterene-Hydrochlorothiazid | 21 | $279 | $13 |
| Hydralazine | 12 | $274 | $23 |
| Lovastatin | 17 | $236 | $14 |
| Benazepril | 13 | $124 | $10 |
2016: 38 drugs
| Eliquis | 287 | $140,963 | $491 |
| Xarelto | 74 | $51,660 | $698 |
| Zetia | 24 | $14,367 | $599 |
| Crestor | 31 | $9,070 | $293 |
| Pradaxa | 12 | $8,706 | $726 |
| Metoprolol | 237 | $8,574 | $36 |
| Diltiazem 24hr Er | 31 | $5,004 | $161 |
| Atorvastatin | 183 | $4,042 | $22 |
| Valsartan | 58 | $3,804 | $66 |
| Losartan | 257 | $2,639 | $10 |
| Amlodipine Besylate | 275 | $2,439 | $9 |
| Carvedilol | 184 | $2,176 | $12 |
| Flecainide Acetate | 42 | $1,915 | $46 |
| Potassium Chloride | 38 | $1,848 | $49 |
| Lisinopril | 212 | $1,816 | $9 |
| Diltiazem 24hr Cd | 16 | $1,710 | $107 |
| Bisoprolol | 51 | $1,463 | $29 |
| Amiodarone | 23 | $1,358 | $59 |
| Pravastatin | 22 | $986 | $45 |
| Enalapril Maleate | 25 | $955 | $38 |
| Simvastatin | 90 | $872 | $10 |
| Chlorthalidone | 17 | $806 | $47 |
| Torsemide | 41 | $804 | $20 |
| Metoprolol | 86 | $799 | $9 |
| Cartia Xt | 19 | $764 | $40 |
| Clopidogrel | 38 | $740 | $19 |
| Spironolactone | 54 | $685 | $13 |
| Furosemide | 108 | $630 | $6 |
| Hydrochlorothiazide | 93 | $486 | $5 |
| Irbesartan | 18 | $401 | $22 |
| Allopurinol | 19 | $390 | $21 |
| Isosorbide Mononitrate Er | 23 | $386 | $17 |
| Triamterene-Hydrochlorothiazid | 27 | $352 | $13 |
| Atenolol | 42 | $316 | $8 |
| Nitrostat | 12 | $281 | $23 |
| Lovastatin | 15 | $274 | $18 |
| Sotalol | 13 | $130 | $10 |
| Lorazepam | 14 | $107 | $8 |
2015: 42 drugs
| Xarelto | 146 | $74,323 | $509 |
| Eliquis | 98 | $51,337 | $524 |
| Zetia | 36 | $13,683 | $380 |
| Pradaxa | 21 | $13,600 | $648 |
| Crestor | 36 | $11,567 | $321 |
| Metoprolol | 230 | $10,001 | $43 |
| Valsartan | 79 | $9,982 | $126 |
| Atorvastatin | 192 | $3,797 | $20 |
| Diltiazem 24hr Er | 13 | $3,123 | $240 |
| Potassium Chloride | 46 | $2,673 | $58 |
| Losartan | 237 | $2,029 | $9 |
| Amlodipine Besylate | 271 | $2,000 | $7 |
| Carvedilol | 173 | $1,861 | $11 |
| Flecainide Acetate | 30 | $1,661 | $55 |
| Lisinopril | 232 | $1,629 | $7 |
| Pravastatin | 45 | $1,621 | $36 |
| Simvastatin | 113 | $1,267 | $11 |
| Metoprolol | 142 | $1,146 | $8 |
| Cartia Xt | 22 | $1,006 | $46 |
| Enalapril Maleate | 25 | $967 | $39 |
| Furosemide | 135 | $836 | $6 |
| Bisoprolol | 46 | $810 | $18 |
| Isosorbide Dinitrate | 12 | $659 | $55 |
| Chlorthalidone | 15 | $587 | $39 |
| Clopidogrel | 41 | $540 | $13 |
| Levothyroxine | 15 | $539 | $36 |
| Isosorbide Mononitrate Er | 42 | $529 | $13 |
| Hydrochlorothiazide | 87 | $470 | $5 |
| Allopurinol | 13 | $431 | $33 |
| Diltiazem 24hr Cd | 15 | $413 | $28 |
| Spironolactone | 43 | $402 | $9 |
| Amiodarone | 30 | $393 | $13 |
| Lovastatin | 25 | $353 | $14 |
| Atenolol | 42 | $292 | $7 |
| Triamterene-Hydrochlorothiazid | 24 | $292 | $12 |
| Nitrostat | 19 | $284 | $15 |
| Irbesartan | 26 | $256 | $10 |
| Torsemide | 12 | $180 | $15 |
| Lorazepam | 15 | $162 | $11 |
| Digoxin | 11 | $158 | $14 |
| Benazepril | 18 | $152 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $130 | $12 |
2014: 42 drugs
| Xarelto | 131 | $60,779 | $464 |
| Diovan | 57 | $18,320 | $321 |
| Pradaxa | 27 | $12,971 | $480 |
| Metoprolol | 238 | $12,015 | $50 |
| Crestor | 51 | $11,931 | $234 |
| Zetia | 38 | $10,595 | $279 |
| Eliquis | 19 | $7,918 | $417 |
| Valsartan | 31 | $6,516 | $210 |
| Atorvastatin | 175 | $6,407 | $37 |
| Amlodipine Besylate | 284 | $2,799 | $10 |
| Losartan | 198 | $2,660 | $13 |
| Lisinopril | 233 | $2,014 | $9 |
| Flecainide Acetate | 42 | $1,975 | $47 |
| Carvedilol | 141 | $1,778 | $13 |
| Potassium Chloride | 33 | $1,523 | $46 |
| Simvastatin | 138 | $1,485 | $11 |
| Pravastatin | 41 | $1,422 | $35 |
| Metoprolol | 113 | $1,144 | $10 |
| Valsartan-Hydrochlorothiazide | 25 | $1,126 | $45 |
| Clopidogrel | 30 | $941 | $31 |
| Toprol Xl | 12 | $939 | $78 |
| Diltiazem 24hr Er | 31 | $854 | $28 |
| Cartia Xt | 15 | $813 | $54 |
| Furosemide | 148 | $811 | $5 |
| Bisoprolol | 27 | $743 | $28 |
| Hydrochlorothiazide | 108 | $558 | $5 |
| Digox | 23 | $505 | $22 |
| Spironolactone | 38 | $493 | $13 |
| Lovastatin | 28 | $441 | $16 |
| Atenolol | 62 | $425 | $7 |
| Triamterene-Hydrochlorothiazid | 27 | $419 | $16 |
| Levothyroxine | 14 | $305 | $22 |
| Benazepril | 20 | $280 | $14 |
| Sotalol | 12 | $277 | $23 |
| Warfarin | 14 | $271 | $19 |
| Irbesartan | 15 | $270 | $18 |
| Losartan-Hydrochlorothiazide | 17 | $258 | $15 |
| Enalapril Maleate | 15 | $235 | $16 |
| Isosorbide Mononitrate Er | 16 | $180 | $11 |
| Synthroid | 13 | $174 | $13 |
| Nitrostat | 12 | $156 | $13 |
| Lorazepam | 19 | $154 | $8 |
2013: 42 drugs
| Diovan | 90 | $25,002 | $278 |
| Pradaxa | 45 | $15,991 | $355 |
| Metoprolol | 241 | $11,010 | $46 |
| Zetia | 44 | $10,452 | $238 |
| Xarelto | 14 | $6,615 | $473 |
| Atorvastatin | 151 | $6,472 | $43 |
| Crestor | 21 | $5,437 | $259 |
| Lipitor | 12 | $3,653 | $304 |
| Losartan | 191 | $3,290 | $17 |
| Amlodipine Besylate | 266 | $3,094 | $12 |
| Carvedilol | 163 | $2,596 | $16 |
| Micardis Hct | 16 | $2,213 | $138 |
| Potassium Chloride | 63 | $2,006 | $32 |
| Valsartan-Hydrochlorothiazide | 29 | $2,003 | $69 |
| Simvastatin | 167 | $1,802 | $11 |
| Lisinopril | 174 | $1,625 | $9 |
| Flecainide Acetate | 24 | $1,472 | $61 |
| Clopidogrel | 36 | $1,443 | $40 |
| Metoprolol | 137 | $1,382 | $10 |
| Toprol Xl | 19 | $1,314 | $69 |
| Diltiazem Er | 27 | $1,173 | $43 |
| Furosemide | 181 | $1,038 | $6 |
| Bisoprolol | 16 | $985 | $62 |
| Lovastatin | 34 | $755 | $22 |
| Pravastatin | 33 | $635 | $19 |
| Torsemide | 18 | $586 | $33 |
| Sotalol | 13 | $533 | $41 |
| Hydrochlorothiazide | 88 | $462 | $5 |
| Spironolactone | 27 | $423 | $16 |
| Triamterene-Hctz | 22 | $409 | $19 |
| Diltiazem 24hr Cd | 14 | $405 | $29 |
| Atenolol | 74 | $400 | $5 |
| Levothyroxine | 24 | $368 | $15 |
| Benazepril | 26 | $354 | $14 |
| Losartan-Hydrochlorothiazide | 15 | $338 | $23 |
| Gemfibrozil | 16 | $335 | $21 |
| Enalapril Maleate | 24 | $302 | $13 |
| Pantoprazole | 13 | $270 | $21 |
| Digox | 27 | $195 | $7 |
| Chlorthalidone | 18 | $183 | $10 |
| Omeprazole | 11 | $172 | $16 |
| Warfarin | 13 | $152 | $12 |
Money from drug and device companies
$140 in 2025
| 2025 | 1 | 1 | None | $140 |
| 2019 | 1 | 1 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Repatha | $140 | 1 payment
|
See the published payment
| Amgen | Meals · 2025-10-29 | Repatha | $140 |
See earlier years (2019)
2019: $113
| Medtronic Vascular | 3f | $113 | 1 payment
|
Professional record
- NPI
- 1861453151
- Licence
- CA G77614California G77614: Current · expires 2027-06-30
- Trained
- Warren Alpert Medical School of Brown University, 1990
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-03-28
- NPI last updated
- 2020-06-19
- NPI record certified
- 2020-06-19
This is when the NPI record was last certified, not a medical board exam.